Tolerance induction through mixed chimerism | springermedizin.at

Springer Medizin Österreich

nach oben

European Surgery

Erschienen in:

01.03.2002 | Review

Tolerance induction through mixed chimerism

verfasst von: Th. Wekerle, M.D., P. Blaha, R. Asari, M. Schmid, Ch. Kiss, E. Roth, F. Mühlbacher

Erschienen in: European Surgery | Ausgabe 2/2002

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Ciglitazone, ligand of peroxisome proliferator-activated receptor-γ, inhibits vascular endothelial growth factor activity

Nächster Artikel Invited commentary to: ‘Tolerance induction through mixed chimerism’ (Eur. Surg. 2002;34:131–135)

Titel: Tolerance induction through mixed chimerism
verfasst von: Th. Wekerle, M.D.
P. Blaha
R. Asari
M. Schmid
Ch. Kiss
E. Roth
F. Mühlbacher
Publikationsdatum: 01.03.2002
Verlag: Springer-Verlag
Erschienen in: European Surgery / Ausgabe 2/2002
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI: https://doi.org/10.1046/j.1563-2563.2002.02020.x

Weitere Artikel der Ausgabe 2/2002

Editorial

Main Topics: Biotechnology In Vascular Surgery

Angiogenic gene therapy with vascular endothelial growth factor — Hope or hype?

Main Topics: Biotechnology In Vascular Surgery

Gene transfer of naked VEGF plasmid induces the formation of microvessels but not mature collaterals in ischaemic limb muscles

Main Topics: Biotechnology In Vascular Surgery

Congress Announcement

Congress Announcement

Ciglitazone, ligand of peroxisome proliferator-activated receptor-γ, inhibits vascular endothelial growth factor activity

Main Topics: Biotechnology In Vascular Surgery